The study assessed the overall diagnostic accuracy of the Merlin CP-GEP Test for predicting sentinel node metastases and recurrence risk The Merlin CP-GEP Test demonstrated strong predictive and ...
The MarketWatch News Department was not involved in the creation of this content. -- Sentinel lymph node (SLN) status alone is not sufficient as node negative patients still experience relapse and ...
Sentinel lymph node (SLN) status alone is not sufficient as node negative patients still experience relapse and melanoma-related death. Validates Merlin CP-GEP's prognostic power: Identifying tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results